cardiology database
ESC 2011 Paris conference coverage
News clinical trials presented at ESC 2011 Paris
ARISTOTLE, 2011
-
apixaban 5mg twice daily
vs warfarin adjusted for an INR between 2 and 3
atrial fibrillation - antithrombotics - primary prevention of thromboembolic events
atrial fibrillation - direct factor Xa inhibitors - all type of patients
atrial fibrillation - new oral anticoagulants - all type of patients
NMA Bayer - new oral anticoagulants - all types of patients
NMA BMS apixaban Afib - new oral anticoagulants - ARISTOFLE
Choose another conferences:
AHA 2012 Los Angeles
ESC 2012 München
AHA 2011 Orlando
TCT 2011
ESC 2011 Paris
ACC 2011 New Orleans
ESC 2010 Stockholm
ACC 2010 Atlanta
European Society of Cardiology 2009 Congress
ACC.09/i2 Orlando 2009
AHA 2009 Orlando
TCT 2010
AHA 2010 Chicago
ACC 2012
|